#25-8 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Nordea Bank Abp: Repurchase of own shares on 10.01.2025
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares10.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.01.2025
Reading Time: < 1 minute Stock Exchange Release 10.01.2025 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.01.2025 Date 10.01.2025 Exchange transaction Buy Share class FSKRS Amount 2000 Average price/share 14.7915 EUR Highest price/share 14.8200 EUR Lowest price/share
Ghosts of Tabor Announces First-Ever Twitch Drops Event Coming January 24-27
Reading Time: 2 minutes MEDIA ALERT – Beyond Frames Entertainment and Combat Waffle Studios today announced that, in collaboration with Twitch, Ghosts of Tabor will host its first Twitch Drops event from 11 am EST on Friday, January 24 through 8 am EST on
SlotsRank Explores Top Branded Slot Games
Reading Time: 2 minutes Stockholm, Sweden – January 2025 – SlotsRank, a renowned platform for online slot reviews and rankings, has released its latest insights into branded slot games, a category redefining the online casino landscape. By combining globally recognized franchises with innovative slot mechanics, branded
Klaria signs license agreement for Sumatriptan Alginate film in Europe with CNX Therapeutics
Reading Time: 5 minutes Klaria Pharma Holding AB (publ) (“Klaria” or the “Company”) announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the “Product”), a pharmaceutical product based on Klaria’s patented alginate films for fast and reliable administration via the oral mucosa,
ABAX disputes Greater Than’s claims in its entirety
Reading Time: < 1 minute Read original Larvik (Norway), January 10, 2025 – In reference to the press release of January 10th issued by Greater Than, accusing ABAX of infringing upon contractually regulated intellectual property (IP) rights, ABAX categorically refutes these allegations. ABAX find it
STENOCARE A/S announces guarantee commitments in ongoing rights issue
Reading Time: 3 minutes STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“Stenocare” or the “Company”) announces that the Company has received a legally binding guarantee commitment of 2 mDKK from Exelity AB, securing approximately 9.9 percent of the total issue corresponding to approximately
2025 Roadmap: Boomerang Partners Targets Growth in iGaming
Reading Time: 2 minutes Boomerang Partners has shared its plans for 2025. This rapidly growing global company is preparing for new products and global expansion. After a successful 2024, it is ready to strengthen its position in iGaming with a key focus on sports betting. Boomerang
Invitation to monthly digital events and presentations of quarterly report
Reading Time: < 1 minute Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during